Appeal No. 2002-1630 Page 16 Application No. 09/175,713 “encompass sequences comprising fragments as well as sequences identified by homology. They thus encompass sequences that vary widely from what is disclosed, and the skilled artisan would not predictably be able to use such molecules as disclosed.” Examiner’s Answer, page 15. We reverse the rejection as it is applied to claims 6-9. These claims are of much narrower scope than, for example, claim 5. Claim 6 is representative. It encompasses the specific polynucleotide sequence of SEQ ID NO:6 (also defined by reference to an ATCC accession number), polynucleotides encoding the same amino acid, and the complements of these polynucleotides. These parts of the claim do not seem to bother the examiner. The examiner’s basis for rejecting the claim as nonenabled are the two other types of polynucleotide encompassed by claim 6: “(d) a polynucleotide encoding a protein comprising an amino-terminal fragment of the amino acid sequence of SEQ ID NO:10; . . . [and] (f) a polynucleotide capable of hybridizing at either (i) 4xSSC at 65°C or (ii) 50% formamide and 4xSSC at 42°C, to any of the polynucleotides specified in (a)-(e) above.” The examiner has not adequately explained why practicing these parts of claim 6 would have required undue experimentation. With respect to fragments, the examiner has presented no explanation of why undue experimentation would have been required to distinguish between active and inactive amino-terminal fragments of a specified polypeptide sequence. With respect to “hybridizing” polynucleotides, such as those recited in part (f) of claim 6, the specification defines the recited conditions as beingPage: Previous 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 NextLast modified: November 3, 2007